Advertisement

Ads Placeholder
Loading...

Aclarion, Inc.

ACONWNASDAQ
Healthcare
Medical - Healthcare Information Services
$0.03
$-0.01(-22.34%)
U.S. Market opens in 22h 30m

Aclarion, Inc. Fundamental Analysis

Aclarion, Inc. (ACONW) shows weak financial fundamentals with a PE ratio of -0.26, profit margin of -95.52%, and ROE of -0.00%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position68025184237.20%
PEG Ratio-0.00
Current Ratio14.81

Areas of Concern

ROE-0.00%
Operating Margin-93.13%
We analyze ACONW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -25256988.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-25256988.0/100

We analyze ACONW's fundamental strength across five key dimensions:

Efficiency Score

Weak

ACONW struggles to generate sufficient returns from assets.

ROA > 10%
-0.00%

Valuation Score

Excellent

ACONW trades at attractive valuation levels.

PE < 25
-0.26
PEG Ratio < 2
-0.00

Growth Score

Weak

ACONW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ACONW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
14.81

Profitability Score

Weak

ACONW struggles to sustain strong margins.

ROE > 15%
-0.02%
Net Margin ≥ 15%
-95.52%
Positive Free Cash Flow
No

Key Financial Metrics

Is ACONW Expensive or Cheap?

P/E Ratio

ACONW trades at -0.26 times earnings. This suggests potential undervaluation.

-0.26

PEG Ratio

When adjusting for growth, ACONW's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Aclarion, Inc. at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at -1689966.83 times EBITDA. This is generally considered low.

-1689966.83

How Well Does ACONW Make Money?

Net Profit Margin

For every $100 in sales, Aclarion, Inc. keeps $-95.52 as profit after all expenses.

-95.52%

Operating Margin

Core operations generate -93.13 in profit for every $100 in revenue, before interest and taxes.

-93.13%

ROE

Management delivers $-0.00 in profit for every $100 of shareholder equity.

-0.00%

ROA

Aclarion, Inc. generates $-0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.00%

Following the Money - Real Cash Generation

Operating Cash Flow

Aclarion, Inc. generates limited operating cash flow of $-7.18T, signaling weaker underlying cash strength.

$-7.18T

Free Cash Flow

Aclarion, Inc. generates weak or negative free cash flow of $-7.18T, restricting financial flexibility.

$-7.18T

FCF Per Share

Each share generates $-13465637.66 in free cash annually.

$-13465637.66

FCF Yield

ACONW converts -3762884.12% of its market value into free cash.

-3762884.12%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.26

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

25.14

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

14.81

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

-0.00

vs 25 benchmark

How ACONW Stacks Against Its Sector Peers

MetricACONW ValueSector AveragePerformance
P/E Ratio-0.2628.45 Better (Cheaper)
ROE-0.00%763.00% Weak
Net Margin-9551.87%-45265.00% (disorted) Weak
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio14.812795.60 Strong Liquidity
ROA-0.00%-16588.00% (disorted) Weak

ACONW outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Aclarion, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ